Cytotoxic T lymphocyte antigen 4-immunoglobulin G is a potent adjuvant for experimental allergen immunotherapy

Allergen-specific immunotherapy (SIT) is the only treatment for allergic diseases that targets allergen-specific T helper type 2 (Th2) cells, which are the cause of the disease. There is an unmet requirement for adjuvants that increase the clinical efficacy of SIT allowing application of lower doses...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Maazi, H, Shirinbak, S, den Boef, L E, Fallarino, F, Volpi, C, Nawijn, M C, van Oosterhout, A J M
Natura: Artigo
Lingua:Inglês
Pubblicazione: Blackwell Science Inc 2013
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3719937/
https://ncbi.nlm.nih.gov/pubmed/23480191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12041
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi